Reuters logo
in 3 months
BRIEF-Oryzon Genomics obtains $0.3 mln grant from Alzheimer's Drug Discovery Foundation
April 24, 2017 / 6:24 AM / in 3 months

BRIEF-Oryzon Genomics obtains $0.3 mln grant from Alzheimer's Drug Discovery Foundation

1 Min Read

April 24 (Reuters) - Oryzon Genomics SA:

* Obtains new $ 0.3 million grant from Alzheimer's Drug Discovery Foundation (ADDF) to develop companion marker for its ORY-2001 epigenetic drug

* Under terms of grant, ADDF has received a stake of 0.24 percent in the company at a price of 3.410 euro ($3.70) per share, reaches 0.77 percent of common stock

Source text: bit.ly/2p88PKq

Further company coverage: ($1 = 0.9204 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below